Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology

This review  explores the  prognosis  and  treatment outcomes  for individuals with  focal epilepsy , a common neurological condition where seizures originate in specific brain regions. While roughly  two-thirds  of patients achieve  seizure freedom  using  anti-seizure medications (ASMs) , approximately  one-third  develop  drug-resistant epilepsy (DRE) . The authors highlight that despite the av...

This research analyzes the  global surge of early-onset Parkinson’s disease (EOPD)  between 1990 and 2021, revealing that incidence and prevalence rates have nearly  tripled worldwide . The study highlights a disproportionately high burden in  Latin American countries , likely driven by specific genetic mutations and environmental factors such as  arsenic contamination . While the disease is becom...

New-onset refractory status epilepticus (NORSE) and its subcategory, febrile infection-related epilepsy syndrome (FIRES) , are rare clinical presentations characterized by the sudden onset of drug-resistant seizures in individuals without prior epilepsy. These conditions typically follow a biphasic course , beginning with a catastrophic acute phase of status epilepticus followed by a chronic phase...

This prospective, population-based cohort study focuses on the long-term outcomes of  seizures and epilepsy in patients with untreated cerebral cavernous malformations (CCMs) . The research tracked 300 patients in Scotland for a median of 15 years to assess the risk of developing seizures and experiencing seizure recurrence without surgical intervention for the CCMs. Key findings include that the ...

A comprehensive research paper by Laurini et al. (2025) investigating  phenotype-genotype correlations  in early-onset Charcot-Marie-Tooth type 1B (CMT1B), a neuropathy linked to Myelin Protein Zero (MPZ) variants. The authors analyzed data from a large cohort of 75 Italian patients to understand how different MPZ mutations affect disease severity and progression, categorizing variants as either ...

This article  focuses on the  risk of cardiac disease  in a population cohort of individuals with Myotonic Dystrophy Type 1 (DM1) and Type 2 (DM2). This study, conducted by Nicholas E. Johnson et al. using data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), investigated the frequencies of cardiac arrhythmias and cardiomyopathy. The  key findings  indicate th...

The paper presents a single-center prospective cohort study from Latvia examining the use of the anti-CD20 monoclonal antibody, rituximab, as a treatment for  refractory myasthenia gravis (MG) . Conducted on nine patients who had failed conventional treatments, the study evaluated the effects of a single low dose over a six-month period. Results indicated significant clinical improvement, marked b...

This neurological update details the substantial advancements in treating  Myasthenia Gravis (MG) , emphasizing transformative developments since 2016. A major focus is the proven efficacy of  thymectomy  in non-thymomatous disease and the introduction of novel targeted immunotherapies, including  complement inhibitors  and  FcRN inhibitors  that actively remove pathogenic antibodies from circulat...

The episode summarizes an  academic review article  from  JAMA  focusing on  Peripheral Neuropathy . This extensive review outlines the condition's importance, including its  prevalence  and  causes , with diabetes being the most common etiology. Furthermore, the article  details the condition's pathology , its  various clinical presentations , and the  diagnostic methods  employed for ide...

Diagnostic Controversies in Chronic Inflammatory Demyelinating Polyneuropathy

Two papers, an  original article  and follow up data from a  randomized clinical trial  on the use of rituximab for new-onset generalized Myasthenia Gravis (MG) has been reviewed. The studies assess the effectiveness and safety of rituximab over several years, concluding that  early exposure to the treatment may offer sustained benefits  in disease activity and reduce the need for rescue treatment...

The episode combines two papers discussing both the potentiyal use of CAR T cells therapy in various  autoimmune neurological diseases  like Multiple Sclerosis and Myasthenia Gravis, along with potential neurological adverse effects of this treatment.

This article outlines the Active Inference Model, which is one of the proposed pathophysiological mechanisms of functional neurological disorder (FND).

This study presents a systematic review and meta-analysis of the  effectiveness and safety of immunizations  against three major respiratory viruses:  Covid-19, respiratory syncytial virus (RSV), and influenza . Authored by a large team of researchers and published in the  New England Journal of Medicine , the article synthesizes evidence to provide independent guidance for the  2025–2026 respirat...

This article is an excerpt from a natural history study published in  Neurology  in 2025, focusing on the  sensitivity of clinical outcome measures  in assessing adult patients with  Becker Muscular Dystrophy (BMD)  over a three-year period. Researchers aimed to identify which functional tests, such as the  Rise From Floor velocity (RFFv)  and the  North Star Ambulatory Assessment (NSAA) , were mo...

This journal article provides a  practical guide  to understanding and applying the  International League Against Epilepsy (ILAE) updated seizure classification of 2025 . It explains how the new system, which builds on the 2017 classification, enhances clarity and consistency in terminology for  healthcare professionals  managing epilepsy. The classification organizes seizures into  four main clas...

The paper provides  updated 2025 management guidelines  from the  Association of British Neurologists (ABN)  for autoimmune myasthenia gravis (MG). The document outlines several  key updates from previous 2015 guidelines , emphasizing new standard practices such as prescribing daily steroids and recommending  early thymectomy  for certain patient groups. It extensively details the  diagnosis, init...

The papers summarized focus on Cerebral Amyloid Angiopathy (CAA) , particularly the emerging clinical phenomenon of iatrogenic CAA (iCAA) . iCAA is hypothesized to occur following the transmission of Amyloid-β (Aβ) seeds (prions) during medical procedures, such as neurosurgery involving cadaveric dura mater. Key points regarding CAA and iCAA include:• Pathogenesis and Latency: The transmission of...

This   original article  published in the  New England Journal of Medicine   reports the findings of the  ASSET-IT trial , a phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial. This study investigates the  efficacy and safety of early tirofiban infusion  after standard intravenous thrombolysis for patients experiencing acute ischemic noncardioembolic stroke. The tria...

Friedreich’s ataxia is a rare, progressive, autosomal recessive neurodegenerative, multisystem disorder caused by a homozygous GAA repeat expansion in the frataxin gene , resulting in a deficiency of the mitochondrial protein frataxin. This core pathology impairs iron–sulfur cluster biosynthesis and mitochondrial adenosine triphosphate production, leading to mitochondrial dysfunction and increased...

This episode combines three papers to provide a comprehensive overview of  Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) , emphasizing its status as the most common monogenic cerebral small vessel disorder caused by  NOTCH3 gene mutations . These mutations, particularly those altering cysteine residues in the NOTCH3 receptor, lead to the accum...

The two research articles reviewed here compare the clinical presentation of different variants of  hereditary transthyretin-mediated amyloidosis (TTR familial amyloidosis) , particularly focusing on the Val142Ile variant.

This episode reviews  clinical practice guideline  developed for the management of  Spinal Bulbar Muscular Atrophy (SBMA) , also known as Kennedy disease, in Canada. The guideline is prompted by the discovery of a  substantially elevated prevalence  of this rare X-linked recessive neuromuscular disorder among  First Nations and Métis people  in western Canada. It addresses the  diagnosis and compr...

This episode reviews the  VasCog-2-WSO Criteria , which is the 2025 revised consensus diagnostic guidelines for  Vascular Cognitive Impairment and Dementia (VCID) . Developed by an international consortium of experts using a  Delphi consensus process , these criteria update the previous VasCog guidelines to incorporate recent advances in  neuroimaging and biomarkers . The objective was to create a...

This episode reviews 5 publications on  Idiopathic Normal Pressure Hydrocephalus (iNPH) , specifically addressing diagnosis, patient selection for shunting, and long-term treatment outcomes. One article is a systematic review and consensus protocol from the International Parkinson and Movement Disorders Society, which addresses the  lack of standardization in the large-volume lumbar puncture "tap...